<p>WASHINGTON — Canada likely isn’t the main target of U.S. President Donald Trump’s threat to impose a 200 per cent tariff on pharmaceutical imports, an industry representative said Wednesday — but his plan could still put parts of the Canadian sector in peril.</p>

Canada exports less than 5% of all generic meds sold in the U.S., but "could get caught in the crossfire if there are broad-based tariffs."{ai:summary}<p>U.S. President Donald Trump’s proposed 200% tariff on pharmaceutical imports may not primarily target Canada, according to an industry representative. However, the plan could still jeopardize certain segments of the Canadian pharmaceutical sector. #economy</p>

Canadian pharmaceutical industry alarmed after Trump threatens 200% tariff on drug imports

Loading...